User login
To the Editor: I enjoyed the dermatology update in the May 2015 issue.1 I would like to inquire about the clinical management of the patient in case 3, a 58-yearold man with biopsy-proven malignant melanoma surrounded by intense inflammatory infiltrate. The tumor was excised with standard margins, but distal metastases developed 2 years later. The depth of invasion of the primary tumor was not revealed, but could this patient have benefited from sentinel lymph node biopsy immediately after the initial excision?
- Fernandez A. Dermatology update: the dawn of targeted treatment. Cleve Clin J Med 2015; 82:309–320.
To the Editor: I enjoyed the dermatology update in the May 2015 issue.1 I would like to inquire about the clinical management of the patient in case 3, a 58-yearold man with biopsy-proven malignant melanoma surrounded by intense inflammatory infiltrate. The tumor was excised with standard margins, but distal metastases developed 2 years later. The depth of invasion of the primary tumor was not revealed, but could this patient have benefited from sentinel lymph node biopsy immediately after the initial excision?
To the Editor: I enjoyed the dermatology update in the May 2015 issue.1 I would like to inquire about the clinical management of the patient in case 3, a 58-yearold man with biopsy-proven malignant melanoma surrounded by intense inflammatory infiltrate. The tumor was excised with standard margins, but distal metastases developed 2 years later. The depth of invasion of the primary tumor was not revealed, but could this patient have benefited from sentinel lymph node biopsy immediately after the initial excision?
- Fernandez A. Dermatology update: the dawn of targeted treatment. Cleve Clin J Med 2015; 82:309–320.
- Fernandez A. Dermatology update: the dawn of targeted treatment. Cleve Clin J Med 2015; 82:309–320.